Generics Up-date

REGULATORY

Greg Perry, Director General EGA, congratulates EMEA on its 10 successful years .

Developing new relationships

In a statement delivered at the EMEA’s 10th Anniversary Conference in London on Friday, 11 March, EGA Director General Greg Perry underscored the important new relationship developing between the agency and generic medicines producers.

The EGA has a very special interest in celebrating the EMEA’s 10th Anniversary as this year also sees generic medicines companies in Europe preparing to use the EU’s Centralised Procedure (CP) to obtain authorisation for generic and biosimilar products for the first time.

To date the EGA has focused on its relationship with national medicines agencies, as the generic industry has become the principal user of the current Mutual Recognition Procedure. Whilst our industry will continue to develop ... [ continued ]

Related story:

• The Generics Industry Fast Becoming EU’s Main Source of Medicines

EGA Briefs

MEPs meet EGA Board Members

Mr Phillip Whitehead, MEP and Chairman of the Committee on Internal Market & Consumer Protection told a group of MEPs and members of the EGA Board of Directors at a reception in the European Parliament that “We are thankful to the generic medicines industry for their contribution to bringing down pharmaceutical prices.” He urged MEPs to maintain their efforts to ensure that the generics industry can continue to meet the increasing demand in Europe for affordable medicines

• Report & Photos

New on EGA Web

On the “News Room” page

The latest edition of the EGA FOCUS on Generic Medicines is now posted on the Web site for viewing. This publication is produced in English and French to highlight timely issues facing generic medicines.

• Documents & Positions

Up-coming Events

London - 26-27 May 2005

The key conference of the year dedicated to the latest regulatory developments in the cutting-edge field of biosimilar medicinal products. Early registration is now available on-line.

Malta: 19-22 June 2005

“The most important generics conference of the year.”

Featuring top-level international speakers giving you the latest on: Market Status, Industry and Regional Perspectives • Keys for Competing Successfully in Generics • IP Laws & TRIPS: Understanding the limitations • EU Harmonisation in Scientific Matters? • Projections for the Global Generics Market.

Don't miss the June 19th Pre-conference Seminars on IP Strategies • Licensing for US Markets • EU Legal Framework & Registration.

Berlin - 21-22 November 2005

Mark you calendars now! Details available soon.

London - 2-3 February 2006

Watch for details soon.

• EGA Conferences & Events